Buzzing Stocks: $XOMA, $TWTR, $NFLX
XOMA Corp (NASDAQ:XOMA) has announced that its drug, Gevokizumab, has been granted Orphan Drug Designation by the United Sates FDA. The drug is being developed for the treatment of pyoderma gangrenosum (PG) and the Orphan Drug Designation is granted to those drugs that are novel and are targeted at rare diseases or conditions affecting less than 200,000 patients in the U.S. The company can now get a seven year period of marketing exclusivity, apply for annual grant funding and avail of tax credits for clinical research. XOMA Corp (NASDAQ:XOMA) can also get assistance in clinical research trial design as well as waiver of Prescription Drug User Fee Act filing fees.
Twitter Inc (NYSE:TWTR) continues to innovate in its offerings as the company finds it difficult to find and retain users. Though the user base is still growing at around 30%, many users are preferring not to login in or are login in for shorter duration. This is not acceptable by advertisers, who are the main source of revenues for the company. They prefer users who not only stay longer but are addicted to the social media platform. Facebook Inc (NASDAQ:FB) has user groups that match their requirements. But the problem is with the content at Twitter Inc (NYSE:TWTR). The company is trying innovative means of attracting users and is also trying to integrate images and videos in its mainline streams. During the same time, Facebook was adding 13 million users against Twitter’s 1 million every month.
Netflix, Inc. (NASDAQ:NFLX) and Comcast Corporation (NASDAQ:CMCSA) have entered into a multi year interconnection agreement. Both companies have not revealed the terms of the agreement but such an agreement would have serious repercussions on Netflix, Inc. (NASDAQ:NFLX)’s profit margins. The ramifications would be felt internationally. It appears that the deal is a paid-peering deal under which Netflix will get direct access to Comcast’s broadband network. The earlier agreement was an open connect one under which Netflix was using middlemen like Cogent to gain access.
Latest posts by Viraj Shah (see all)
- Profit For Vale SA (ADR) (NYSE:VALE) But EBITDA Falls Sharply - July 31, 2015
- Royal Dutch Shell plc (ADR) (NYSE:RDS.A) Arctic Icebreaker Finally Sails - July 31, 2015
- Facebook Inc (NASDAQ:FB) Builds A Giant Solar-powered Drone for Internet - July 31, 2015
- ConocoPhillips (COP) Is One Of Shale Companies That Continues To Struggle - July 31, 2015
- All About Penn Virginia Corporation (PVA)’s Earnings - July 31, 2015
Trade FX, Equities and Options with the World's Leading Platform Open an account here , call us at 305 4904 116, or email us to get started.
The Theory And Practice Of "Risk Parity" And Your Money ... read more
German industrial orders, a key measure of demand for goods ... read more
The Technical Outlook For Gold Remains Bearish $GLD Gold's recent ... read more
Ferrari: F1 Free Practice Begins At Monza For Italian Grand ... read more